Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Treasury Shares: 2014-2023

Historic Treasury Shares for Viking Therapeutics (VKTX) over the last 10 years, with Dec 2023 value amounting to $2.2 million.

  • Viking Therapeutics' Treasury Shares changed negligibly% to $6.8 million in Q4 2023 from the same period last year, while for Dec 2023 it was $6.8 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $6.8 million for FY2023, which is negligibly% changed negligibly from last year.
  • As of FY2023, Viking Therapeutics' Treasury Shares stood at $6.8 million, which was down 0.00% from $6.8 million recorded in FY2022.
  • In the past 5 years, Viking Therapeutics' Treasury Shares registered a high of $6.8 million during FY2022, and its lowest value of $6.8 million during FY2022.
  • For the 3-year period, Viking Therapeutics' Treasury Shares averaged around $1.8 million, with its median value being $2.2 million (2023).
  • Data for Viking Therapeutics' Treasury Shares shows a peak YoY surged of 113.29% (in 2022) over the last 5 years.
  • Over the past 5 years, Viking Therapeutics' Treasury Shares (Yearly) stood at $352,726 in 2019, then surged by 92.60% to $679,363 in 2020, then skyrocketed by 51.36% to $1.0 million in 2021, then spiked by 113.29% to $2.2 million in 2022, then remained steady at $2.2 million in 2023.